Caducator

Aplicación Caducator, desarrollada en Android para gestionar la caducidad de productos perecederos de un hogar así como diversas listas de la compra.

Moventaa : Aplicación móvil para la gestión y control de ventas para vendedores

Aplicación desarrollada bajo tecnología Android destinada a la gestión y control de ventas de productos para vendedores.

Salud y Psicología Positiva

Peer-reviewed

ESTRO-HERO survey: Guidelines for equipment and staffing of radiotherapy facilities in the European countries: Final results of the ESTRO-HERO survey

Background and purpose: In planning to meet evidence based needs for radiotherapy, guidelines for the provision of capital and human resources are central if access, quality and safety are not to be compromised. A component of the ESTRO-HERO (Health Economics in Radiation Oncology) project is to document the current availability and content of guidelines for radiotherapy in Europe. Materials and methods: An 84 part questionnaire was distributed to the European countries through their national scientific and professional radiotherapy societies with 30 items relating to the availability of guidelines for equipment and staffing and selected operational issues. Twenty-nine countries provided full or partial evaluable responses. Results: The availability of guidelines across Europe is far from uniform. The metrics used for capital and human resources are variable. There seem to have been no major changes in the availability or specifics of guidelines over the ten-year period since the QUARTS study with the exception of the recent expansion of RTT staffing models. Where comparison is possible it appears that staffing for radiation oncologists, medical physicists and particularly RTTs tend to exceed guidelines suggesting developments in clinical radiotherapy are moving faster than guideline updating. Conclusion: The efficient provision of safe, high quality radiotherapy services would benefit from the availability of well-structured guidelines for capital and human resources, based on agreed upon metrics, which could be linked to detailed estimates of need

ESTRO-HERO survey: Radiotherapy equipment and departments in the European countries: Final results from the ESTRO-HERO survey

Background: Documenting the distribution of radiotherapy departments and the availability of radiotherapy equipment in the European countries is an important part of HERO the ESTRO Health Economics in Radiation Oncology project. HERO has the overall aim to develop a knowledge base of the provision of radiotherapy in Europe and build a model for health economic evaluation of radiation treatments at the European level. The aim of the current report is to describe the distribution of radiotherapy equipment in European countries. Methods: An 84-item questionnaire was sent out to European countries, principally through their national societies. The current report includes a detailed analysis of radiotherapy departments and equipment (questionnaire items 2629), analyzed in relation to the annual number of treatment courses and the socio-economic status of the countries. The analysis is based on validated responses from 28 of the 40 European countries defined by the European Cancer Observatory (ECO). Results: A large variation between countries was found for most parameters studied. There were 2192 linear accelerators, 96 dedicated stereotactic machines, and 77 cobalt machines reported in the 27 countries where this information was available. A total of 12 countries had at least one cobalt machine in use. There was a median of 0.5 simulator per MV unit (range 0.31.5) and 1.4 (range 0.44.4) simulators per department. Of the 874 simulators, a total of 654 (75%) were capable of 3D imaging (CT-scanner or CBCToption). The number of MV machines (cobalt, linear accelerators, and dedicated stereotactic machines) per million inhabitants ranged from 1.4 to 9.5 (median 5.3) and the average number of MV machines per department from 0.9 to 8.2 (median 2.6). The average number of treatment courses per year per MV machine varied from 262 to 1061 (median 419). While 69% of MV units were capable of IMRT only 49% were equipped for image guidance (IGRT). There was a clear relation between socio-economic status, as measured by GNI per capita, and availability of radiotherapy equipment in the countries. In many low income countries in Southern and Central-Eastern Europe there was very limited access to radiotherapy and especially to equipment for IMRT or IGRT. Conclusions: The European average number of MV machines per million inhabitants and per department is now better in line with QUARTS recommendations from 2005, but the survey also showed a significant heterogeneity in the access to modern radiotherapy equipment in Europe. High income countries especially in Northern-Western Europe are well-served with radiotherapy resources, other countries are facing important shortages of both equipment in general and especially machines capable of delivering high precision conformal treatments (IMRT, IGRT)

ESTRO-HERO survey: Radiotherapy staffing in the European countries: Final results from the ESTRO-HERO survey

Background: The ESTRO Health Economics in Radiation Oncology (HERO) project has the overall aim to develop a knowledge base of the provision of radiotherapy in Europe and build a model for health economic evaluation of radiation treatments at the European level. The first milestone was to assess the availability of radiotherapy resources within Europe. This paper presents the personnel data collected in the ESTRO HERO database. Materials and methods: An 84-item questionnaire was sent out to European countries, through their national scientific and professional radiotherapy societies. The current report includes a detailed analysis of radiotherapy staffing (questionnaire items 4760), analysed in relation to the annual number of treatment courses and the socio-economic status of the countries. The analysis was conducted between February and July 2014, and is based on validated responses from 24 of the 40 European countries defined by the European Cancer Observatory (ECO). Results: A large variation between countries was found for most parameters studied. Averages and ranges for personnel numbers per million inhabitants are 12.8 (2.530.9) for radiation oncologists, 7.6 (019.7) for medical physicists, 3.5 (012.6) for dosimetrists, 26.6 (1.978) for RTTs and 14.8 (0.461.0) for radiotherapy nurses. The combined average for physicists and dosimetrists is 9.8 per million inhabitants and 36.9 for RTT and nurses. Radiation oncologists on average treat 208.9 courses per year (range: 99.9348.8), physicists and dosimetrists conjointly treat 303.3 courses (range: 85757.7) and RTT and nurses 76.8 (range: 25.7156.8). In countries with higher GNI per capita, all personnel categories treat fewer courses per annum than in less affluent countries. This relationship is most evident for RTTs and nurses. Different clusters of countries can be distinguished on the basis of available personnel resources and socio-economic status. Conclusions: The average personnel figures in Europe are now consistent with, or even more favourable than the QUARTS recommendations, probably reflecting a combination of better availability as such, in parallel with the current use of more complex treatments than a decade ago. A considerable variation in available personnel and delivered courses per year however persists among the highest and lowest staffing levels. This not only reflects the variation in cancer incidence and socio-economic determinants, but also the stage in technology adoption along with treatment complexity and the different professional roles and responsibilities within each country. Our data underpin the need for accurate prediction models and long-term education and training programmes

A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study)

Background: Since barrier protection measures to avoid contact with allergens are being increasingly developed, we assessed the clinical efficacy and tolerability of a topical nasal microemulsion made of glycerol esters in patients with allergic rhinitis. Methods: Randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial in which adult patients with allergic rhinitis or rhinoconjunctivitis due to sensitization to birch, grass or olive tree pollens received treatment with topical microemulsion or placebo during the pollen seasons. Efficacy variables included scores in the mini-RQLQ questionnaire, number and severity of nasal, ocular and lung signs and symptoms, need for symptomatic medications and patients" satisfaction with treatment. Adverse events were also recorded. Results: Demographic characteristics were homogeneous between groups and mini-RQLQ scores did not differ significantly at baseline (visit 1). From symptoms recorded in the diary cards, the ME group showed statistically significant better scores for nasal congestion (0.72 vs. 1.01; p = 0.017) and mean total nasal symptoms (0.7 vs. 0.9; p = 0.045). At visit 2 (pollen season), lower values were observed in the mini-RQLQ in the ME group, although there were no statistically significant differences between groups in both full analysis set (FAS) and patients completing treatment (PPS) populations. The results obtained in the nasal symptoms domain of the mini-RQLQ at visit 2 showed the highest difference (−0.43; 95% CI: -0.88 to 0.02) for the ME group in the FAS population. The topical microemulsion was safe and well tolerated and no major discomforts were observed. Satisfaction rating with the treatment was similar between the groups. Conclusions: The topical application of the microemulsion is a feasible and safe therapy in the prevention of allergic symptoms, particularly nasal congestion.

Total synthesis of lamellarin D and analogs library

Larnellarins are a group of marine natural products isolated from the prosobranch mollusc Lamellaria sp., the ascidian Didemnum sp., and the sponge Dendrilla Cactos. Several of them exhibit interesting biological activities. Natural as well as synthetic lamellarins should be excellent candidates for the development of new drugs due to their unique skeletal structure and their important biological activities especially as antitumor agents. Lamelarin O has been recently characterized as a topoisomerase 1-targeted anti tumor agent. A variety of synthetic approaches have been developed for this family of alkaloids. Herein we describe a new route to the synthesis of Lamellarin D, from a methyl 2-pyrrolecarboxylate. Transformation of the starting material into the scaffold, a substituted 5,6-dihydropyrrolo (2,l ­a)isoquinoline (5,6-DHPl), was afforded by N-alkylation followed by intramolecular Heck cyclization. From this scaffold the synthetic strategy is based on two sequential regioselective bromination!Suzuki cross-coupling reactions which permitted the introduction of differently substituted aryl groups on positions 1 and 2 followed by oxidation, deprotection, and lactonization.

Els enciams no són només per a l'amanida, també tenen cautxú

El cautxú és un polímer d'origen biològic que s'obté del làtex, un fluid d'aspecte lletós que es pot extreure de diverses plantes i que es fa servir com a primera matèria per manufacturar molts productes. També es pot produir de manera sintètica a partir de derivats del petroli, però de moment el natural presenta avantatges importants, com ara que és més elàstic i resistent a l'abrasió. Un nou estudi ha trobat una nova font de làtex: els enciams. L'hortalissa mediterrània podria passar de ser només un producte per a l'amanida a tenir un interès industrial, com ara fer rodes.

Innovació oberta per sortir de la crisi econòmica

L'increment del nombre de llocs de treball no pot estar només associat a fer-ne aparèixer de nous basant-nos en les noves empreses derivades dels resultats de la recerca. Crear petites empreses basades en productes de les TIC o de disseny de molècules, per citar-ne dos jaciments típics, està molt bé, però des de qualsevol punt de vista, no permetria una disminució substancial del nombre de desocupats. Amb prou feines servirien per donar sortida als joves que surten d'escoles i universitats, més ben formats que una gran proporció dels desocupats

Les estratègies de recerca i innovació a Catalunya

Hi ha prou indicadors que demostren que la suma dels àmbits de salut (recerca universitària i de centres públics, hospitals en recerca bàsica, translacional i tecnològica, qualitat de la tecnologia i serveis sanitaris, empreses farmacèutiques i de biotecnologia de l'àmbit de salut), la bioenginyeria, l'electrònica, la nanobiotecnologia, l'aplicació de les TIC, etc. és una de les màximes fortaleses de Catalunya

Com generar i finançar els nuclis d'innovació

La qüestió és com generar i finançar els nuclis d'innovació. A parer meu, la transferència, més enllà dels discursos, no és una prioritat. Les prioritats estan en els pressupostos i en l'assignació dels recursos humans. Només s'estan considerant, i no prou, els productes de l'activitat dels investigadors que podrien produir beneficis a curt termini. Jo no actuaria així. Estic convençut que amb pocs recursos i petits incentius a un teòric fons perdut als projectes dels investigadors, el coneixement transferible identificat creixeria substancialment

Control del pes per a les entrades/sortides de vehicles amb matèria primera

S'ha optat per la utilització de la tecnologia .NET per desenvolupar un projecte que s'instal·larà a tots els centres de producció del Grup Lecta, la funció més important del qual serà el control d'entrades/sortides i pesatge dels vehicles que abasteixen, principalment de matèria primera així com d'altres productes, a cadascuna de les fàbriques del grup.

BestWishes

El projecte consisteix en la creació d'una plataforma tecnològica, mitjançant tecnologia .NET i anomenada BestWishes, que té com a objectiu proporcionar als consumidors una eina per gestionar productes preferits, comprar o reservar aquests productes i ser una plataforma de comerç electrònic per a comerços que venen productes de regal.

Estudi d'implantació d'un sistema de videoconferència a la Universitat de Lleida

L'auge vertiginós de les tecnologies de la informació i la comunicació (TIC) durant els darrers anys ha creat empremta en la vida quotidiana de la societat mundial, i cada dia hi han més eines al nostre abast que ens faciliten la vida si en sabem treure profit. En l'àmbit universitari, la docència i la recerca universitàries per la seva naturalesa són sectors on ja fa temps que aprofiten les TIC per millorar-ne l'excel·lència. Per exemple, l'e-learning és un tipus d'ensenyament a través d'Internet on professor i alumne poden estar distants geogràficament. La majoria d'universitats ja implementen aquest tipus d'ensenyament comptant amb algun servei de campus virtual com a eina d'ús àmpliament coneguda i gaudeixen de nombrosos avantatges que beneficien tant a l'estudiantat com al professorat i al personal d'administració i serveis. Els sistemes de videoconferència, juntament amb la millora de les connexions a Internet a les llars, conjuminen un altra vessant de les TIC que tenen un gran impacte potencial per a la societat, i així, el fet de poder comunicar-se a distància amb veu i imatge en temps real comporta un estalvi de temps i diners força considerable. L'aprofitament d'aquestes oportunitats que ofereixen les TIC provocarà una reinvenció dels centres educatius i potenciarà un aprenentatge cada cop més pràctic i agradable. L'objectiu del present projecte es estudiar sistemes de videoconferència que puguin ser utilitzats per ells mateixos o de forma integrada al campus virtual de la Universitat de Lleida. A més, també seran objecte d'avaluació els mecanismes i metodologies estàndards per ajudar a la selecció del producte que més s'escaigui a les necessitats de la UdL. Així doncs, forma part de l’abast d’aquest projecte la definició de les necessitats que pot cobrir una eina de videoconferència integrada al campus virtual i l'estudi de les possibles aplicacions futures que se li pot donar per part de la comunitat universitària. I en funció d’aquesta definició, i dels sistemes TIC actuals amb els quals hi pot haver dependència, es definiran els requeriments que posteriorment caldrà valorar per totes les solucions de sistemes de videoconferència destacables per tal de poder seleccionar la més indicada. Durant la seva durada s’abordaran tot un seguit d'etapes per tal de triar un producte final, iniciant en primer lloc l'anàlisi prèvia de l'escenari plantejat, l'anàlisi de requeriments de la universitat, l'estudi de metodologies de valoració de projectes o eines informàtiques, la recerca de productes de videoconferència destacables i la posterior valoració, l'estudi de costs i retorn de la inversió del projecte, i finalment, la definició d'un escenari de pla pilot dins la pròpia universitat